Abeona Therapeutics Inc.
ABEO
$6.91
-$0.04-0.58%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -39.21% | -70.15% | |||
| Gross Profit | 43.24% | 70.15% | |||
| SG&A Expenses | 75.24% | 27.46% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 17.56% | 18.32% | |||
| Operating Income | -15.54% | -18.32% | |||
| Income Before Tax | 1,133.71% | -29.44% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 1,004.76% | -29.44% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1,004.76% | -29.44% | |||
| EBIT | -15.54% | -18.32% | |||
| EBITDA | -15.92% | -18.97% | |||
| EPS Basic | 957.62% | -26.56% | |||
| Normalized Basic EPS | -120.79% | -26.57% | |||
| EPS Diluted | 806.00% | -26.56% | |||
| Normalized Diluted EPS | -74.04% | -26.57% | |||
| Average Basic Shares Outstanding | 5.52% | 2.26% | |||
| Average Diluted Shares Outstanding | 33.87% | 2.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||